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Abstract
Background: Dynamic intraventricular obstruction has been observed in patients with left ventricular ballooning 
syndrome (LVBS) and has been hypothesized as a possible mechanism of the syndrome. The aim of this study was to 
assess the prevalence and significance of dynamic intraventricular obstruction in patients with LVBS.
Methods and Results: Dobutamine stress echocardiography was carried out in 22 patients with LVBS (82% apical), all 
women, aged 68 ± 9 years. At baseline 1 patient had a > 30 mmHg LV gradient; during stress a LV gradient > 30 mm Hg 
developed in 6/21 patients (28%) and was caused by systolic anterior motion of the mitral valve in the 3 patients with 
severe gradient (mean 116 ± 29 mmHg), who developed mitral regurgitation and impaired apical wall motion and by 
obstruction at mid-ventricular level in the other 3 with a moderate gradient (mean 46 ± 16 mmHg). Compared with 
patients without obstruction those with obstruction had a greater mean septal thickness (11.6 ± .6 vs 9.8. ± 3, p < .01), 
a higher prevalence of septal hypertrophy (71% vs 7%, p < .005) and a higher peak wall motion score index (1.62 ± .4 vs 
1.08 ± .4, p < .01).
Conclusion: Spontaneous or dobutamine-induced dynamic LV obstruction is documented in 32% of patients with 
LVBS, is correlated with the presence of septal hypertrophy and may play a role in the development of LVBS in this 
subset of patients. In those without septal hypertrophy a dynamic obstruction is rarely induced with dobutamine and 
is unlikely to be a major pathogenetic factor of the syndrome.
Left ventricular ballooning syndrome (LVBS) is a recently
described acute cardiac syndrome mimicking acute myo-
cardial infarction, characterized by reversible regional
apical or midventricular dysfunction whose pathogenetic
mechanisms are as yet undefined [1-4]. Sympathetic
stimulation and increased catecholamine release second-
ary to emotional stress leading to myocardial stunning
are likely to play an important role [5,6]. Recently it has
been hypothesized that in the presence of a localized
proximal-mid septal hypertrophy, stress-related
increased sympathetic tone may induce dynamic intra-
ventricular obstruction, that in turn increases myocardial
wall stress distal to the obstruction and decreases
regional subendocardial perfusion leading to the develop-
ment of akinesia and dilation in the apical region [7].
Dobutamine administration can induce a dynamic LV
obstruction in a significant number of patients undergo-
ing the stress testing [8-11] and could therefore repro-
duce the spontaneous event in patients with LVABS. We
therefore carried out dobutamine stress echocardiogra-
phy in a group of patients with LVBS to assess the preva-
lence and pathogenetic role of dynamic intraventricular
obstruction in LVBS.
Methods
Study population
The study population was composed of 22 consecutive
patients admitted with an acute coronary syndrome who
fulfilled the diagnostic criteria for LVBS proposed by
Mayo Clinic group [4] including: 1) Chest pain associated
with new ST-segment elevation or T wave inversion in ≥
2 contiguous leads; 2) Absence of significant (≥
50%)obstructive coronary artery disease and of an acute
plaque rupture at coronary angiography carried out
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within 48 hours from onset of symptoms; 3) Transient
reversible akinesia or dyskinesia and dilatation involving
either the midventricular and apical segments with basal
LV hyperkinesia (apical ballooning) or the midventricular
segments with normal or hyperkinetic basal and apical
segments (midventricular variant); 4) No evidence of
recent major head trauma, intracranial bleeding, pheo-
chromocytoma, myocarditis or hypertrophic cardiomyo-
pathy. All patients were included in the Italian
Multicenter Registry on Takotsubo syndrome.
Dobutamine stress echocardiography
The test was carried out at a mean of 9 ± 14 days from
admission. Beta-blocking therapy was withdrawn 24
hours before the test. At baseline LV wall thickness and
dimensions were measured by M-mode echocardiogra-
phy in parastemal long axis view according to standard
methods; a ≥ 12 mm end-diastolic wall thickness was
considered indicative of wall hypertrophy. Dobutamine
was administered at an initial dose of 5 mcg/kg/min for 5
minutes, with increase to 10 and 20, 30 and 40 mcg/kg/
min for 5 minutes each under electrocardiographic and
echocardiographic monitoring. The peak LV velocity was
measured at rest, at the end of each stage and at peak
s t r e s s  b y  c o n t i n u o u s  w a v e  Do p p l e r  f r o m  a p i ca l  4 - o r  5
chamber view. A pressure gradient >30 mmHg with a late
peaking was considered significant for a dynamic intra-
ventricular obstruction [1]; the site of LV obstruction was
identified by pulsed and color Doppler; systolic anterior
motion of the anterior mitral leaflet was searched for in
multiple views. LV end-diastolic and end-systolic volume
using the area-length method and ejection fraction were
measured in the apical 4 chamber view at baseline and at
peak stress. Digitized basal, low dose, peak dose and
recovery images were displayed in a quad screen format
for off-line comparison. Regional wall motion was
assessed on a 16-segment LV model [12] as previously
described and a wall motion score index was calculated at
baseline and at peak stress [13]. A new or worsening wall
motion abnormality compared to baseline was consid-
ered diagnostic of myocardial ischemia. Myocardial via-
bility was judged to be present in basally hypokinetic or
akinetic segments when normalization or improvement
in myocardial thickening and motion was observed in at
least 2 contiguous segments after dobutamine. The test
was interrupted according to previously described crite-
ria [13]. At the end of the test intravenous propranolol (1-
5 mg) was administered. All patients gave their informed
consent to the test.
Coronary Angiography
Left ventriculography and multiplane coronary angiogra-
phy were carried out according to standard methods.
Ejection fraction was calculated by the area-length
method. Coronary artery disease was defined as a ≥ 50%
reduction in the luminal diameter of a major coronary
artery. The TIMI flow grade classification and TIMI
frame count were used to assess coronary blood flow in
the 3 coronary arteries and calculated as previously
described [14]. A TIMI frame count ≤ 27 frames was con-
sidered normal. The study complied with the Declaration
of Helsinki on the research on humans; the study proto-
col was approved by the local ethical committee. All
patients gave written informed consent.
Statistical analysis
Data are presented as mean ± SD. Continuous variables
were compared using a paired or unpaired Student's t
test; categorical variables were compared by Fischer exact
test.
Results
Clinical findings
The main clinical findings of the patients studied are
shown in table 1. All patients were women with a mean
age of 68 ± 9 years (range 54-84). No patient had a history
of angina. Presenting symptoms were chest pain in 21
patients, dyspnea in 2 and dizziness or syncope in 4. Cor-
onary angiography showed normal coronary arteries in
14 patients (64%) and <50% stenosis of 1 vessel in 8 (36%);
TIMI frame count in the left anterior descending, left cir-
cumflex and right coronary arteries was abnormally pro-
longed in 32, 32 and 36% of patients respectively. Mean
LV ejection fraction was 48 ± 8%; 10/22 patients (45%)
Table 1: Clinical characteristics of the patients studied
Age (yrs) 68 ± 9(range 54-84)
Sex (M/W) 0/22
Hypertension 17 (77%)
Dyslipidemia 11 (50%)
Family history of CAD 8 (36%)
Diabetes mellitus 1 (4%)
Smoking 1 (4%)
Previous angina 0
Triggering event 11 (50%)
ECG in the acute phase:
ST-segment elevation 13 (59%)
Negative T waves 7 (32%)
Minor ST-T abnormalities 2 (9%)
Coronary angiography
Normal coronary arteries 14 (64%)
<50% stenosis 1 vessel 8 (32%)
Ejection fraction 48 ± 8%
Abbreviations: M = men; W = women; CAD = Coronary artery 
disease.Previtali et al. Cardiovascular Ultrasound 2010, 8:11
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had an ejection fraction <50%. LV angiography showed a
typical apical ballooning pattem in 18 patients (82%) and
a midventricular ballooning with sparing of the apical
segments in 4 (18%). In the acute phase a dynamic intra-
ventricular gradient was documented in 3 patients (14%).
Dobutamine stress echocardiography
In basal conditions 5 patients showed a complete recov-
ery of regional function while apical wall motion abnor-
malities were still present in 17. A localized proximal-mid
septal hypertrophy was found in 6/22 patients (27%); no
patient had a concentric LV hypertrophy. One patient
showed a dynamic intraventricular gradient of 150
mmHg associated with systolic anterior motion of the
mitral valve and mitral regurgitation and did not undergo
DSE. In the remaining 21 patients heart rate increased
from 67 ± 10 at baseline to 106 ± 18 beats/min at peak
stress (p < .001) and systolic blood pressure increased
from l30 ± 30 to 133 ± 27 mmHg (NS). Due to reduced
diastolic filling time LV end-diastolic volume decreased
from 99 ± 27 at baseline to 74 ± 30 ml at peak stress (p <
.001) and end-systolic volume decreased from 48 ± 15 to
39 ± 23 ml (p < .002); mean walI motion score index
improved from 1.4 ± .3 to 1.2 ± .4 (p < .01). A dynamic
intraventricular gradient > 30 mmHg (mean 81 ± 44
mmHg, range 150-35 mmHg) with a late peaking devel-
oped in 6/21 patients (28%); the obstruction was localized
in the outflow tract and caused by systolic anterior
motion of the anterior mitral leaflet in 3 patients (mean
gradient 116 ± 29 mmHg) (Figure 1) and at papillary mus-
cle level in the other 3 (mean gradient 46 ± 16 mmHg)
(Figure 2). The changes in regional wall motion in rela-
tion to dobutamine-induced obstruction are shown in
Table 2. Of the 2 patients with a mild to moderate
obstruction (gradient < 40 mmHg), both at papillary
muscle level, 1 had normal baseline regional function and
showed no change with dobutamine and 1 showed a par-
tial recovery of regional wall motion abnormalities. Of
the 4 patients with a severe obstruction (gradient > 40
mm Hg) 3 showed a biphasic response (improvement at
low dobutamine doses followed by impaired apical wall
motion associated with the development of obstruction)
and 1 a direct deterioration of function in the apical
region. In 3/4 of these patients the obstruction was local-
ized in the outflow tract and associated with severe mitral
regurgitation secondary to systolic anterior motion of the
mitral valve (Additional files 1 and 2). No correlation was
found between stenosis of left anterior descending coro-
nary artery and stress echo positivity. On the other hand,
of the 15 patients without obstruction, 6 showed a com-
plete recovery and 6 a partial recovery of baseline
regional wall motion abnormalities, 1 had no significant
change and 2 had a normal regional function already at
baseline. During the test > l mm ST-segment depression
occurred in 1/6 (17%) patients with and in 0/15 without
obstruction and positive T waves in the precordial leads
developed in 3/6 patients with and in 4/15 without
obstruction. No patients complained of chest pain or dys-
pnea during the test. In all cases dynamic obstruction and
regional wall motion abnormalities rapidly disappeared
after intravenous propranol. No major complication
occurred during the test. Both patients with and those
without contractile reserve during the test showed a com-
plete recovery of regional function during follow-up.
Comparison or patients with and without obstruction
Table 3 compares the clinical, angiographic and stress
echocardiographic findings of the 7 patients with sponta-
neous or dobutamine induced obstruction with those of
the 15 without obstruction. The main clinical characteris-
tics, baseline and peak stress heart rate, blood pressure,
LV volumes and ejection fraction were not significantly
different between the 2 groups. Compared with patients
without obstruction those with obstruction had a signifi-
cantly greater mean septal thickness (11.6 ± .6 vs 9.8 ± .3,
p < .01) and a higher prevalence of localized septal hyper-
trophy (71% vs 7%, p < .005). Despite similar baseline wall
motion score index, patients with a dynamic gradient had
a significantly higher wall motion score index at peak
stress (1.62 ± 4 vs 1.08 ± .4, p < 0.01) indicating an impair-
ment in regional wall motion associated with the obstruc-
tion. In relation to the site of LV ballooning, a dynamic
obstruction was documented in 6/18 patients with apical
and in 1/4 with midventricular ballooning (33% vs 25%,
NS).
Discussion
Prevalence and significance of dynamic LV obstruction in 
LVBS
Many pathophysiological mechanisms, including direct
toxic effects of catecholamine overflow, epicardial coro-
nary artery spasm and diffuse coronary microvascular
dysfunction, have been hypothesized as possible causes
of LVBS, but none of them has been convincingly demon-
strated [4]. The close temporal relation with psychologi-
cal stress and increased plasma levels of catecholamines
documented in some studies suggest that sympathetic
stimulation and toxic effects of catecholamines may play
a major role [5,6], however, other studies have docu-
mented no significant elevation in plasma catecholamine
and cortisol levels [15]. Bybee et al found an increased
TIMI frame count in all major coronary arteries of
patients with LVBS [16]; other studies showed a transient
impairment of coronary flow reserve in the acute phase
with early recovery paralleling the recovery of wall
motion abnormalities [17,18]. These findings suggest that
coronary microvascular dysfunction may play a pathoge-
netic role, but it has not been as yet clarified whetherPrevitali et al. Cardiovascular Ultrasound 2010, 8:11
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Figure 1 Severe dobutamine induced-obstruction. Severe dobutamine-induced dynamic LV obstruction (peak velocity 5 m/sec corresponding to 
a gradient of 100 mm Hg, panel B) caused by systolic anterior motion of the mitral valve (panel A) and associated with severe mitral regurgitation 
(panel C) in a patient with apical ballooning.
Figure 2 Moderate dobutamine-induced obstruction. Moderate dobutamine-induced dynamic LV obstruction (peak velocity 3 m/sec corre-
sponding to a gradient of 36 mm Hg) caused by the iuxtaposition of the posterior papillary muscle to the hypertrophic septum in another patient 
with apical ballooning.Previtali et al. Cardiovascular Ultrasound 2010, 8:11
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microvascular dysfunction is a primary or secondary
phenomenon. Coronary epicardial spasm has been docu-
mented in a significant proportion of Japanese patients
[1,2], but is rare in Caucasian patients [3-6,19]. During
the acute phase a transient dynamic intraventricular gra-
dient was documented in 18% of patients in the largest
population of LVBS so far reported [1]; in other smaller
studies the prevalence of dynamic obstruction in the
acute phase ranged from 12.5% [16] to 23% [5]. These
findings and the association of dobutamine-induced
dynamic intraventricular gradient with worsening of api-
cal wall motion recently reported in 2 patients with LVBS
and septal hypertrophy [7] suggested a possible pathoge-
netic role for dynamic intraventricular obstruction in
LVBS. The prevalence of dobutamine-induced dynamic
obstruction in our patients with LVBS is similar to that
reported by previous studies in patients undergoing dob-
utamine stress echocardiography for evaluation of coro-
nary artery disease [8-11,20-22], that showed a
prevalence ranging from 13% in the study by Heinle et al
[10] to 53% by Wagner et al [9]. Therefore, the develop-
ment of a mild to moderate intraventricular gradient dur-
ing dobutamine stress is frequent and may have no major
clinical significance in the majority of patients with LVBS
as in the general population. The significant association
found in our patients between dynamic intraventricular
gradient and septal hypertrophy is in keeping with the
studies by Khanal et al [21] and Wagner et al [9], who
showed that dobutamine-induced LV cavity obliteration
was associated with female sex and LV hypertrophy.
Thus, the dynamic intraventricular obstruction docu-
mented in our patients does not seem to be a specific fea-
ture of LVBS, but rather depends upon the presence of a
localized septal hypertrophy that is frequently found in
elderly women. On the other hand, in a minority of
patients with LVBS a severe dynamic intraventricular
obstruction can play a role in the development of LVBS
by increased myocardial wall stress and decreased suben-
docardial perfusion in the apical region leading to myo-
cardial ischemia on a hemodynamic basis; this hypothesis
is supported by the fact that all 4 patients with severe
dobutamine-induced obstruction showed a significant
impairment in apical wall motion. The hypothesis of a
coronary spasm during dobutamine stress or at the time
of beta-blocking infusion as the mechanism of the wall
motion abnormalities observed in these patients is
unlikely because none of these patients developed ST-
segment elevation, which is the hallmark of coronary
artery spasm and the wall motion changes occurred
before administration of beta-blockers and were abol-
ished by them. On the basis of our data, it is not possible
to assess whether dynamic LV obstruction plays a pri-
mary pathogenetic role, leading to the development of an
apical ballooning as suggested by Merli et al [7], or is sec-
ondary to the distortion of the LV geometry caused by
apical akinesia and basal hyperkinesia and acts as a per-
petuating mechanism of the ballooning. Another impor-
tant finding of the study is the association of a major
dynamic obstruction with the development of severe
mitral regurgitation due to systolic anterior motion of the
anterior mitral leaflet in 15% of patients with LVBS.
Severe mitral regurgitation increases pulmonary capillary
pressure and decreases LV forward stroke volume and
may therefore be an important yet unrecognized mecha-
nism contributing to acute LV failure and shock reported
in 20% to 40% of patients with LVBS [1,4,17]. Acute
mitral regurgitation due either to systolic anterior motion
of the anterior mitral leaflet or to displacement of the
papillary muscle with impaired leaflet coaptation has
been recently reported in 20% of patients with LVBS and
has been associated with a worse prognosis [23]. On the
other hand, our study demonstrates the absence of a
spontaneous or dobutamine-induced dynamic LV gradi-
ent in >65% of patients with LVBS; this finding suggests
that in the majority of patients with LVBS the develop-
ment of the syndrome is not related to a dynamic intra-
ventricular obstruction elicited by increased sympathetic
tone.
Clinical implications
Dobutamine stress echocardiography may be a useful
tool for assessing the presence and significance of LV
dynamic obstruction in patients with LVBS and for clini-
cal decision making. However, the safety of the test in this
setting has not been as yet assessed and further studies
on a larger number of patients are warranted. Beta-block-
ing drugs decrease LV contractility and can prevent the
development of dynamic intraventricular gradient and
Table 2: Changes in apical wall motion in relation to 
dobutamine-induced obstruction in the population 
studied.
Dynamic 
obstruction
(n = 6)
No dynamic 
obstruction
(n = 15)
Biphasic 
response
30
Direct 
impairment
10
No changes 11
Partial 
improvement
16
Complete 
normalization
06
Normal baseline 
wall motion
02Previtali et al. Cardiovascular Ultrasound 2010, 8:11
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should therefore be the treatment of choice for patients
with dobutamine-induced dynamic LV obstruction. The
subgroup of patients who develop a severe outflow
obstruction associated with major mitral regurgitation
are at a higher risk of acute LV failure in the case of recur-
rences and should benefit from chronic beta-blocking
therapy at maximal tolerated doses. and from intravenous
beta-blockade if episodes of apical ballooning with
dynamic obstruction recur.
Additional material
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MP planned the study, performed and interpreted the echocardiographic
stress tests and wrote the manuscript; RC collected the clinical data, performed
and interpreted the echocardiographic stress tests and reviewed the manu-
script; AR performed the angiographic studies and reviewed the manuscript;
SP collected the clinical data, performed the echocardiographic stress tests
and reviewed the manuscript. All the authors have red and approved the final
manuscript.
Author Details
From Department of Cardiology, IRCCS Fondazione Policlinico San Matteo, 
University of Pavia School of Medicine, Pavia, Italy
References
1. Tsuchihashi K, Ueshima K, Uchida T, Ohmura N, Kimura K, Owa M, 
Yoshiyama M, Miyazaki S, Haze K, Hogawa H, Honda T, Hase M, Kai R, Morii 
L: Transient Left Ventricular Apical Ballooning without coronary artery 
stenosis: a novel heart syndrome mimicking acute myocardial 
infarction. Angina pectoris-myocardial infarction investigations in 
Japan.  J Am Coll Cardiol 2001, 38:11-18.
2. Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Kono Y, 
Umemura T, Nakamura S: Tako-tsubo-like left ventricular dysfunction 
with ST-segment elevation: a novel cardiac syndrome mimicking acute 
myocardial infarction.  Am Heart J 2002, 143:448-455.
3. Desmet WJR, Adriaenssens BFM, Dens JAY: Apical ballooning of the left 
ventricule: first series in white patients.  Heart 2003, 89:1027-1031.
4. Bybee K, Kara T, Pradas A, Lerman A, Barsness G, Wright S, Rihal C: 
Systematic review: Transient Left Ventricular Apical Ballooning: a 
syndrome that mimics ST-segment elevation myocardial infarction.  
Ann Intern Med 2004, 141:858-865.
5. Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, 
Maron BJ: Acute and reversible cardiomyopathy provoked by stress in 
women from the United States.  Circulation 2005, 111:472-479.
6. Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Schulman SP, 
Gerstenblith G, Wu KC, Rade JJ, Bivalacqua T Jr, Champion HC: 
Neurohumoral features of myocardial stunning due to sudden 
emotional stress.  N Eng J Med 2005, 352:539-548.
Additional file 1 Example of dobutamine-induced dynamic obstruc-
tion in one of the patient studied. Apical 4-chamber view in basal condi-
tions showing no evidence of dynamic obstruction and mitral regurgitation 
and normal apical wall motion.
Additional file 2 Apical 4-chamber view during dobutamine stress 
showing severe mitral regurgitation due to mitral SAM and impaired 
apical wall motion.
Received: 22 January 2010 Accepted: 9 April 2010 
Published: 9 April 2010
This article is available from: http://www.cardiovascularultrasound.com/content/8/1/11 © 2010 Previtali et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cardiovascular Ultrasound 2010, 8:11
Table 3: Comparison of patients with (group 1) and without (group 2) dynamic intraventricular obstruction.
Group 1 Group 2 p-value
Age (years) 67 ± 9 68 ± 9 ns
Hypertension (%) 85 73 ns
IVS thickness (mm) 11.6 ± .6 9.8 ± .3 <0.01
PW thickness (mm) 9.8 ± .6 8.7 ± .1 ns
Septal hypertrophy (%) 71 7 <0.01
BPs basal (mmHg) 131 ± 29 129 ± 27 ns
BPd basal (mmHg) 74 ± 10 69 ± 14 ns
HR basal (b/min) 70 ± 8 66 ± 12 ns
HR dobutamine (b/min) 101 ± 18 108 ± 18 ns
LVEDV basal (ml) 99 ± 29 99 ± 28 ns
LVEDV dobutamine (ml) 81 ± 29 72 ± 32 ns
LVESV basal (ml) 44 ± 19 48 ± 14 ns
LVESV dobutamine (ml) 34 ± 23 40 ± 24 ns
LVEF basal (%) 54 ± 5 48 ± 14 ns
LVEF dobutamine (%) 61 ± 16 67 ± 7 ns
WMSI basal 1.44 ± .4 1.29 ± .4 ns
WMSI dobutamine 1.62 ± .4 1.08 ± .4 <0.01
The patient with dynamic obstruction in basal conditions is included in group 1.
Abbreviations: IVS = interventricular septum, PW = Posterior wall; BPs = Systolic blood pressure; BPd = Diastolic blood pressure; HR = Heart 
rate; LVEDV = Left ventricular end-diastolic volume; LVESV = Left ventricular end systolic volume; LVEF = Left ventricular ejection fraction; 
WMSI = Wall motion score index.Previtali et al. Cardiovascular Ultrasound 2010, 8:11
http://www.cardiovascularultrasound.com/content/8/1/11
Page 7 of 7
7. Merli E, Sutcliffe S, Gori M, Sutherland GR: Tako-Tsubo cardiomyopathy: 
new insights into the possible underlying pathophysiology.  Eur J 
Echocardiography 2006, 7:53-61.
8. Pellikka P, Oh J, Bailey K, Nichols B, Monahan K, Tajik A: Dynamic 
intraventricular obstruction during dobutamine stress 
echocardiography. A new observation.  Circulation 1992, 86:1429-1432.
9. Wagner S, Mohr-Kahaly S, Nixdorff U, Kuntz S, Menzel T, Kolsch B, Meinert 
R, Meyer J: Intraventricular obstruction in dobutamine stress 
echocardiography: determinants of their development and clinical 
sequelae.  Z Kardiol 1997, 86:327-335.
10. Heinle SK, Tice FD, Kisslo J: Hypotension during dobutamine stress 
echocardiography: is it related to dynamic intraventricular 
obstruction?  Am Heart J 1995, 130:314-317.
11. Dawn B, Paliwal VS, Raza ST, Mastali K, Longaker RA, Stoddard MF: Left 
ventricular outflow tract obstruction provoked during dobutamine 
stress echocardiography predicts future chest pain, syncope, and near 
syncope.  Am Heart J 2005, 179:908-916.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, 
Gutgesell H, Reichek N, Sahn D, Schnittiger I: Recommendations for 
quantification of the left ventricle by two-dimensional 
ehocardiography. American Society of Echocardiography Committee 
on Standards, Subcommittee on quantification of two-dimensional 
echocardiogram.  J Am Soc Echocardiogr 1989, 2:358-367.
13. Previtali M, Lanzarini L, Fetiveau R, Poli A, Ferrario M, Falcone C, Mussini A: 
Comparison of dobutamine stress echocardiography, dipyridamole 
stress echocardiography and exercise stress testing for diagnosis of 
coronary artery disease.  Am J Cardiol 1993, 72:865-870.
14. Gibson CM, Shoming A: Coronary and myocardial angiography. 
Angiographic assessment of both epicardial and myocardial perfusion.  
Circulation 2004, 109:3096-3105.
15. Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasead A: Stress hormone 
and circulating biomarker profile of apical ballooning syndrome 
(Takotsubo cardiomyopathy). Insights into the clinical significance of 
B-natriuretic peptide and troponin levels.  Heart 2009, 95:1436-1441.
16. Bybee KT, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Scott 
Wright R, Rihal CS: Clinical characteristics and thrombolysis in 
myocardial infaction frame count in women with transient left 
ventricular apical ballooning syndrome.  Am J Cardiol 2004, 94:343-346.
17. Rigo F, Sicari R, Citro R, Ossena G, Buja P, Picano E: Diffuse, marked 
impairment in coronary microcirculation in stress cardiomyopathy: a 
Doppler transthoracic echo study.  Ann Med 2009, 2:1-9.
18. Meimoun P, Malaquin D, Sayah S, Benali T, Luycx-Bore A, Levy F, Zemir H, 
Tribouilloy C: The coronary flow reserve is transiently impaired in tako-
tsubo cardiomyopathy: a prospective study using serial Doppler 
transthoracic echocardiography.  J Am Soc Echocardiogr 2008, 1:72-77.
19. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E: Apical 
Ballooning Syndrome or Tako-Tsubo cardiomyopathy: a systematic 
review.  Eur Heart J 2006, 27:1523-1529.
20. Hashimoto Y, Reid CL, Gardin JM: Left ventricular cavitary geometry and 
dynamic intracavitary left ventricular obstruction during dobutamine 
stress echocardiography.  Am J Card Imaging 1996, 10:163-169.
21. Khanal S, Daggubati R, Gaalla A, Shah PM, Pai RG: Left ventricular cavity 
obliteration during dobutamine stress echocardiography is associated 
whit female sex and left ventricular size and function.  J Am Soc 
Echocardiogr 1998, 11:957-960.
22. Luria D, Klutstein W, Rosenmann D, Shaheen J, Sergey S, Tzivoni D: 
Prevalence and significance of left ventricular outflow gradient during 
dobutamine echocardiography.  Eur Heart J 1999, 2:386-392.
23. Parodi G, Del Pace S, Salvadori C, Carrabba N, Olivotto I, Gensini GF: Left 
Ventricular Apical Ballooning Syndrome as a novel cause of acute 
mitral regurgitation.  J Am Coll Cardiol 2007, 50:647-651.
doi: 10.1186/1476-7120-8-11
Cite this article as: Previtali et al., Dobutamine stress echocardiography for 
assessing the role of dynamic intraventricular obstruction in left ventricular 
ballooning syndrome Cardiovascular Ultrasound 2010, 8:11